About International Journal of Clinical Reviews

   

The International Journal of Clinical Reviews (ISSN 2044-3323) has been developed to provide physicians with easy access to succinct, expert-authored summaries of key developments in rapidly-changing areas of medicine in order to facilitate integration of clinically-relevant data into medical practice.

All content is commissioned based on recommendations of topics and authors from the Editorial Advisory Board, and all content is peer reviewed prior to publication to ensure fair balance and scientific and medical accuracy.

The International Journal of Clinical Reviews is published online only. Full access to current and archived content is on a pay-per-article basis, but specific open-access content is made available each month.

Correspondence

We look forward to receiving your suggestions for content that deserves to be featured, and on any matter that might improve the journal.

 

Please address all correspondence to:

Remedica Medical Education and Publishing Ltd.
Commonwealth House
1 New Oxford Street
London, WC1A 1NU
UK

 

Tel: +44 (0)20 7759 2999 Fax: +44 (0)20 7759 2951

Email: info@remedicajournals.com

 

Editorial Team: Kirsten Miles, George Posford
Editorial Director: Scott Millar
Publishers: Ian Ackland-Snow, Simon Kirsch

Design and Artwork: AS&K Skylight Creative Services

ISSN: 2044-3323 (Online)


Publisher's Statement

© 2010–2012 Remedica Medical Education and Publishing.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory.

References

MORE IN THIS SECTION

SUBMIT AN ARTICLE